Ivabradine Versus Beta-blockers in the Treatment of Inappropriate Sinus Tachycardia

• Status: Completed
• Trial end date: 2016-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to prospectively compare the effectiveness and safety of ivabradine and beta-blockers in the treatment of inappropriate sinus tachycardia.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Policlinico Casilino ASL RMB
• Treatments: Adrenergic beta-Antagonists

Criteria

Inclusion Criteria:

• Inappropriate sinus tachycardia (HR >100 bpm at rest ECG and/or medium Holter ECG HR >90 bpm)

• Age > 18 years;

Exclusion Criteria:

• Secondary causes of sinus tachycardia;

• Structural heart diseases,

• Postural orthostatic tachycardia syndrome;

• Sinus nodal reentrant tachycardia;

• Contraindications to beta-blockers;

• Administration of beta-blockers, non-di-hydropiridinic calcium channels antagonists, class I and III anti-arrhythmic drugs or digitalis at the time of enrollment;

• Age < 18 years;

• Inability of giving informed consent;